[First time tuberculin skin test among children in Asaminami-ward, Hiroshima City]

Hirofumi Okuno1

  • 1Asaminami Public Health Center, Hiroshima City, 1-33-14, Furuichi, Asaminami-ku, Hiroshima-shi, Hiroshima 731-0193, Japan. okuno-h@city.hiroshima.jp

Kekkaku : [Tuberculosis]
|November 19, 2003
PubMed

Insights

Tuberculin skin test (TST) results in infants showed higher positive rates in older children. Further research is needed to determine if weak positive reactions indicate tuberculosis infection, as current criteria for treatment were not met.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Context:

  • Study conducted at Asaminami Public Health Center, Hiroshima City, involving 7,398 infants and babies.
  • Tuberculin skin testing (TST) was performed between April 2000 and September 2002.
  • Investigated TST positivity rates and implications in a pediatric population.

Purpose:

  • To analyze the results of tuberculin skin tests in a large cohort of infants and babies.
  • To assess the positivity rates of TST based on age groups (below and above six months).
  • To evaluate the need for chemoprophylaxis based on TST results and clinical criteria.

Summary:

  • First-time TST showed a higher positive rate in children over six months compared to those under six months.
  • Repeat TST in children over six months rarely converted to negative.
  • Six children were recommended for chemoprophylaxis, but did not meet clinical criteria, necessitating further investigation into weak positive reactions.

Impact:

  • Highlights potential age-related differences in TST reactivity in infants.
  • Raises questions about the specificity of weak positive TST reactions for tuberculosis infection in young children.
  • Suggests a need to refine clinical guidelines for chemoprophylaxis in infants with borderline TST results.

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...